APA (7th ed.) Citation

Z, W., X, L., Z, L., R, Y., F, Z., S, X., . . . J, D. (2026). USP13 promotes enzalutamide resistance by catalyzing depolyubiquitination of PCMT1 in prostate cancer. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08824-9

Chicago Style (17th ed.) Citation

Z, Wang, et al. "USP13 Promotes Enzalutamide Resistance by Catalyzing Depolyubiquitination of PCMT1 in Prostate Cancer." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08824-9.

MLA (9th ed.) Citation

Z, Wang, et al. "USP13 Promotes Enzalutamide Resistance by Catalyzing Depolyubiquitination of PCMT1 in Prostate Cancer." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08824-9.